CUTERA

Cutera Appoints Stephana Patton as Chief Legal Officer

November 13, 2023 08:30 AM Eastern Standard Time BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023. “Cutera has a well-established leadership position in the aesthetics industry, and I’m excited to be part of the team that … Continue reading Cutera Appoints Stephana Patton as Chief Legal Officer

David Nieuwsma

David Nieuwsma Joins Kopin Corporation Board of Directors

November 07, 2023 08:30 AM Eastern Standard Time WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN), a leading provider of application specific optical systems and high performance micro-displays for defense, enterprise, consumer and medical products, today announced David Nieuwsma has joined Kopin Corporation’s Board of Directors. “David has extensive operational experience, credibility and is a trusted leader in the defense industry, our primary revenue market. We look forward … Continue reading David Nieuwsma Joins Kopin Corporation Board of Directors

ELUCID

Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk November 09, 2023 07:05 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding. The round was led by Elevage Medical Technologies, with additional participation from industry … Continue reading Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

DAIICHI SANKYO EUROPE

Change in Leadership at Daiichi Sankyo Europe

Masahiro Kato takes over as Managing Director, Oliver Appelhans appointed to Head of the European Specialty Business Unit November 06, 2023 02:00 AM Eastern Standard Time MUNICH–(BUSINESS WIRE)–Today, Daiichi Sankyo Europe GmbH, the European headquarter organisation of the Japanese pharmaceutical company Daiichi Sankyo Co., Ltd., announced the appointment of its new Managing Director Masahiro Kato and new Head of the European Speciality Business Unit, Oliver … Continue reading Change in Leadership at Daiichi Sankyo Europe

Tandem Diabetes Care

Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

November 01, 2023 04:06 PM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for … Continue reading Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer